Optimi Health Establishes Discretionary Equity Facility
Optimi Health Corp., a commercial-stage pharmaceutical company specializing in regulated psychedelic drug products, announced an equity line of credit agreement with Seven Knots, LLC. This discretionary facility allows Optimi to raise up to US$100 million by selling common shares over time, subject to conditions and regulatory approvals. The transa…